Bank of Montreal’s American Renal Associates Holdings, Inc ARA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,233
Closed -$26K 5506
2020
Q4
$26K Buy
2,233
+1,567
+235% +$17.9K ﹤0.01% 4308
2020
Q3
$8K Sell
666
-427
-39% -$2.8K ﹤0.01% 4260
2020
Q2
$7K Buy
+1,093
New +$7.06K ﹤0.01% 4357
2020
Q1
Sell
-2,330
Closed -$24K 5017
2019
Q4
$24K Buy
2,330
+717
+44% +$6.13K ﹤0.01% 4232
2019
Q3
$10K Buy
1,613
+66
+4% +$492 ﹤0.01% 4439
2019
Q2
$12K Buy
1,547
+1,296
+516% +$8.55K ﹤0.01% 4469
2019
Q1
$2K Sell
251
-183
-42% -$2.12K ﹤0.01% 4183
2018
Q4
$5K Buy
434
+93
+27% +$1.59K ﹤0.01% 4127
2018
Q3
$7K Sell
341
-3
-0.9% -$57 ﹤0.01% 4049
2018
Q2
$5K Sell
344
-42,255
-99% -$664K ﹤0.01% 4148
2018
Q1
$803K Buy
42,599
+42,348
+16,872% +$835K ﹤0.01% 2020
2017
Q4
$4K Buy
+251
New +$3.46K ﹤0.01% 3980

Bank of Montreal's ARA Position: Q1 2021 in Review

Bank of Montreal sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 2,233 shares — an estimated $26K sold.

Bank of Montreal first reported a position in ARA in Q4 2017 and held it in 12 quarters. The position peaked at $803K in Q1 2018. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.

  • Bank of Montreal reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,233 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $26K.
  • Bank of Montreal first reported a position in American Renal Associates Holdings, Inc in Q4 2017 and held it in 12 quarters.
  • Bank of Montreal's American Renal Associates Holdings, Inc position peaked at $803K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.

Based on Bank of Montreal's 13F filing for Q1 2021, filed 13 May 2021.